Idex Corp. price target raised to $244 from $211 at RBC Capital

RBC Capital raised the firm’s price target on Idex Corp. (IEX) to $244 from $211 and keeps an Outperform rating on the shares. The company posted a modest Q4 earnings beat with slightly better organic sales and upside 16% in organic orders, including 34% in Health & Science Technologies segment, the analyst tells investors in a research note.